Literature DB >> 33058022

Aligning New Approaches to Accelerate the Development of Non-opioid Analgesic Therapies.

Christine N Sang1, William K Schmidt2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33058022      PMCID： PMC7609808          DOI： 10.1007/s13311-020-00935-1

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN： 1878-7479            Impact factor:   6.088


× No keyword cloud information.
  21 in total

1.  Estimation of clinical trial success rates and related parameters.

Authors:  Chi Heem Wong; Kien Wei Siah; Andrew W Lo
Journal:  Biostatistics       Date:  2019-04-01       Impact factor: 5.899

Review 2.  Emerging Clinical Technology: Application of Machine Learning to Chronic Pain Assessments Based on Emotional Body Maps.

Authors:  Pavel Goldstein; Yoni Ashar; Jonas Tesarz; Mehmet Kazgan; Burak Cetin; Tor D Wager
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 7.620

3.  New tools for studying microglia in the mouse and human CNS.

Authors:  Mariko L Bennett; F Chris Bennett; Shane A Liddelow; Bahareh Ajami; Jennifer L Zamanian; Nathaniel B Fernhoff; Sara B Mulinyawe; Christopher J Bohlen; Aykezar Adil; Andrew Tucker; Irving L Weissman; Edward F Chang; Gordon Li; Gerald A Grant; Melanie G Hayden Gephart; Ben A Barres
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

Review 4.  Considerations in the Assessment of Clinical Benefit with a Focus on Pain: a Regulatory Perspective.

Authors:  Christopher O St Clair; Elektra J Papadopoulos
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 7.620

5.  Comparative transcriptome profiling of the human and mouse dorsal root ganglia: an RNA-seq-based resource for pain and sensory neuroscience research.

Authors:  Pradipta Ray; Andrew Torck; Lilyana Quigley; Andi Wangzhou; Matthew Neiman; Chandranshu Rao; Tiffany Lam; Ji-Young Kim; Tae Hoon Kim; Michael Q Zhang; Gregory Dussor; Theodore J Price
Journal:  Pain       Date:  2018-07       Impact factor: 7.926

6.  Prolonged Use of NMDAR Antagonist Develops Analgesic Tolerance in Neuropathic Pain via Nitric Oxide Reduction-Induced GABAergic Disinhibition.

Authors:  Jun Li; Lin Zhang; Chu Xu; Yu-Hui Lin; Yu Zhang; Hai-Yin Wu; Lei Chang; Ying-Dong Zhang; Chun-Xia Luo; Fei Li; Dong-Ya Zhu
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

Review 7.  Novel Analgesics with Peripheral Targets.

Authors:  Cosmin I Ciotu; Michael J M Fischer
Journal:  Neurotherapeutics       Date:  2020-10-15       Impact factor: 7.620

8.  Mechanisms Involved in Superiority of Angiotensin Receptor Blockade over ACE Inhibition in Attenuating Neuropathic Pain Induced in Rats.

Authors:  Nora Hegazy; Samar Rezq; Ahmed Fahmy
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

Review 9.  Neuromodulation, Specialized Proresolving Mediators, and Resolution of Pain.

Authors:  Xueshu Tao; Michael S Lee; Christopher R Donnelly; Ru-Rong Ji
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

Review 10.  Central Nervous System Targets: Supraspinal Mechanisms of Analgesia.

Authors:  K Bannister; A H Dickenson
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.